B-type natriuretic peptide in reversible myocardial ischaemia

被引:7
|
作者
Chatha, K.
Alsoud, M.
Griffiths, M. J.
Elfatih, A.
Abozguia, K.
Horton, R. C.
Dunmore, S. J.
Gama, R. [1 ]
机构
[1] New Cross Hosp, Dept Clin Chem, Wolverhampton WV10 0QP, W Midlands, England
[2] New Cross Hosp, Dept Cardiol, Wolverhampton WV10 0QP, W Midlands, England
[3] Wolverhampton Univ, Inst Res, Wolverhampton, England
关键词
CORONARY-ARTERY-DISEASE; DYNAMIC EXERCISE; ANGINA-PECTORIS; ATRIAL; SECRETION;
D O I
10.1136/jcp.2005.034702
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Coronary heart disease is associated with increased B-type natriuretic peptides ( BNPs), and, although controversial, may cause exaggerated exercise-induced BNP secretion. We investigated BNP in relation to reversible myocardial ischaemia. Materials and methods: Serum N- terminal proBNP ( NTproBNP) was measured before and after an exercise electrocardiogram test ( ETT) in 14 patients with and 45 patients without exercise- induced myocardial ischaemia. Statistical analysis was carried out on logarithmically transformed data. Results, however, are pre- transformed data. Results: NT- proBNP increased with exercise both in ETTpositive patients ( mean ( SD) 71.4 ( 41.2) v 76.8 ( 44.0) ng/ l; p, < 0.001) and ETT- negative patients (54.0 (61.2) v 60.1 (69.0) ng/ l; p < 0.001). Pre-exercise and post-exercise NTproBNP were higher ( p, < 0.05) in ETT- positive than in ETT-negative patients. Incremental NT- proBNP was similar in ETTpositive ( 4.7 ( 4.2) ng/ l) and ETT- negative ( 6.2 ( 8.6) ng/ l) patients. Conclusion: Serum NT- proBNP concentrations are higher in patients with exercise- induced myocardial ischaemia than in those without. Exercise- induced electrocardiographic myocardial ischaemia, however, is not associated with exaggerated BNP secretion.
引用
收藏
页码:1216 / 1217
页数:2
相关论文
共 50 条
  • [1] Use of B-type natriuretic peptide in the detection of myocardial ischaemia
    Mueller, C.
    Staub, D.
    Zellweger, M.
    Jonas, N.
    Pfisterer, M.
    Perruchoud, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 41 - 41
  • [2] B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors
    Wong, KYK
    McSwiggan, S
    Kennedy, NSJ
    MacWalter, RS
    Struthers, AD
    HEART, 2006, 92 (04) : 487 - 489
  • [3] B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes
    Rana, B. S.
    Davies, J. I.
    Band, M. M.
    Pringle, S. D.
    Morris, A.
    Struthers, A. D.
    HEART, 2006, 92 (07) : 916 - 920
  • [4] B Type natriuretic peptide: a good omen in myocardial ischaemia?
    D'Souza, SP
    Baxter, GF
    HEART, 2003, 89 (07) : 707 - 709
  • [5] B-type natriuretic peptide
    Granel, B
    REVUE DE MEDECINE INTERNE, 2004, 25 (04): : 299 - 302
  • [6] B-type natriuretic peptide
    Kandil, Emad
    Burack, Joshua
    Sawas, Ahmed
    Bibawy, Haidy
    Schwartzman, Alex
    Zenilman, Michael E.
    Bluth, Martin H.
    ARCHIVES OF SURGERY, 2008, 143 (03) : 242 - 246
  • [7] B-type natriuretic peptide infusions in acute myocardial infarction
    Hillock, R. J.
    Frampton, C. M.
    Yandle, T. G.
    Troughton, R. W.
    Lainchbury, J. G.
    Richards, A. M.
    HEART, 2008, 94 (05) : 617 - 622
  • [8] Plasma B-Type Natriuretic Peptide as a Marker of Myocardial Asynchrony
    Ciuraszkiewicz, Katarzyna
    Janion, Marianna
    Dudek, Dariusz
    Gawor, Zenon
    CARDIOLOGY, 2009, 113 (03) : 193 - 197
  • [9] Elevation of B-type natriuretic peptide in the setting of myocardial ischemia
    Sabatine, MS
    Morrow, DA
    De Lemos, JA
    Desai, MY
    Mannting, F
    Cooper, HA
    Antman, EM
    McCabe, CH
    Braunwald, E
    CIRCULATION, 2001, 104 (17) : 485 - 486
  • [10] Use of B-type natriuretic peptide in the detection of myocardial ischemia
    Staub, Daniel
    Nusbaumer, Charly
    Zellweger, Michael J.
    Jonas, Nils
    Wild, Damian
    Pfisterer, Matthias E.
    Mueller-Brand, Jan
    Perruchoud, Andre P.
    Mueller, Christian
    AMERICAN HEART JOURNAL, 2006, 151 (06) : 1223 - 1230